Novel adjunctive therapies for the treatment of tuberculosis - Wikidata - awgldk - TriplyDB

Novel adjunctive therapies for the treatment of tuberculosis

Novel adjunctive therapies for the treatment of tuberculosis

http://www.wikidata.org/entity/Q26829957

about

Roflumilast, a Type 4 Phosphodiesterase Inhibitor, Shows Promising Adjunctive, Host-Directed Therapeutic Activity in a Mouse Model of Tuberculosis.Microglia activation in a pediatric rabbit model of tuberculous meningitis Loperamide Restricts Intracellular Growth of Mycobacterium tuberculosis in Lung Macrophages.Adjunct antibody administration with standard treatment reduces relapse rates in a murine tuberculosis model of necrotic granulomas.

P2860

Q36290586-9E6AD62F-9931-41EB-848E-B44786F98B3B Q37545421-149F0962-0F11-4CC3-84AB-0EAAAFC38E4D Q40596664-E59AD0D1-AD06-493D-B2E9-FDD5733A4100 Q55339701-E0631DC9-FF02-464E-BFF9-E2BC1214A0F3

P2860

Novel adjunctive therapies for the treatment of tuberculosis

http://www.wikidata.org/entity/Q26829957

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Novel adjunctive therapies for the treatment of tuberculosis

@ast

Novel adjunctive therapies for the treatment of tuberculosis

@en

Novel adjunctive therapies for the treatment of tuberculosis

@nl

type

label

Novel adjunctive therapies for the treatment of tuberculosis

@ast

Novel adjunctive therapies for the treatment of tuberculosis

@en

Novel adjunctive therapies for the treatment of tuberculosis

@nl

prefLabel

Novel adjunctive therapies for the treatment of tuberculosis

@ast

Novel adjunctive therapies for the treatment of tuberculosis

@en

Novel adjunctive therapies for the treatment of tuberculosis

@nl

P1433

Q26829957-39A08EE4-B548-4901-976D-6F5411ED610F

P1476

Q26829957-A9E7B684-F673-45F6-9CFD-1229EDC3AF90

P2093

Q26829957-782DE1C4-28A3-43A2-B06D-12CC0EB5BD29

Q26829957-B388E926-4643-46E6-884F-291609E7AC3B

Q26829957-D6D5ED21-E9C6-4141-A2D1-8FF229863056

Q26829957-E9C01B27-AE19-4844-AC03-061689F0E471

Q26829957-F6B2ED70-2BF2-4C01-B7EA-B317A372AD50

P2860

Q26829957-027BE94C-C583-48F4-96DF-3CD0BA2080DB

Q26829957-0650E150-4791-4367-B587-9928CEDEEF3F

Q26829957-0696D112-ECE0-4A8B-8EFB-E00F82A4723E

Q26829957-08D727BD-C0C4-4F5A-9A2E-20FB5259079D

Q26829957-097B6DA3-0D53-4603-8255-B0C4ECC68732

Q26829957-0C836925-E615-45D1-8330-CC8BA92D80E5

Q26829957-0D01F0A9-8835-44CF-9724-D887968E6DE9

Q26829957-0EC457B7-CDD9-4AF1-94BA-63269BDE4B1B

Q26829957-1052B26D-CDF3-4210-8BA2-A493996CC76E

Q26829957-16AE5105-9E86-4E3E-9E91-3AE0C5C29180

P304

Q26829957-C665F643-067F-47C7-9D6A-8757ADE4FFD9

P31

Q26829957-75F23F9F-174C-4629-8E5A-534AD89F44C9

P356

Q26829957-E14AF96F-9ECE-46E4-9B2A-94B824B59526

P407

Q26829957-1E65224C-FE0D-405C-A98D-BB2508A7B9CB

P433

Q26829957-B79A5324-76E9-48AD-9300-B9BDE2C59D42

P478

Q26829957-2B0CA6DF-899F-414A-8813-E7EBAC06AD89

P50

Q26829957-0F658DDC-7A89-47EF-8A29-A1FC1574F50D

P577

Q26829957-6BB167B6-FF41-4017-9044-55D263DA5ACB

P5875

Q26829957-E8CB12FC-B337-4970-94CD-7F34E534C2D9

P698

Q26829957-BCB56952-6E19-4FF5-8F88-888EA2BCA3DB

P921

Q26829957-68CED1DD-D8EA-4BAA-A93E-C7671BFD518A

P932

Q26829957-85211E0C-87B1-4D1A-960E-D6CF7045A660

P356

1566524013666131118112431

P1433

Current Molecular Medicine

P1476

Novel adjunctive therapies for the treatment of tuberculosis

@en

P2093

E A Weinstein

http://www.w3.org/2001/XMLSchema#string

M Maiga

http://www.w3.org/2001/XMLSchema#string

S Gupta

http://www.w3.org/2001/XMLSchema#string

S K Jain

http://www.w3.org/2001/XMLSchema#string

W R Bishai

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs

Corticosteroids for managing tuberculous meningitis

Corticosteroids for tuberculous pleurisy

1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology

P304

385-395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1566524013666131118112431

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Alvaro A Ordonez

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258631989

http://www.w3.org/2001/XMLSchema#string

P698

24236454

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

4484774

http://www.w3.org/2001/XMLSchema#string